Literature DB >> 22949226

De novo heterozygous desmoplakin mutations leading to Naxos-Carvajal disease.

Dagmar I Keller1, Dimitri Stepowski, Christian Balmer, Françoise Simon, Joelle Guenthard, Fabrice Bauer, Peter Itin, Nadine David, Valérie Drouin-Garraud, Véronique Fressart.   

Abstract

STUDY/PRINCIPLES: Arrythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an autosomal-dominantly inherited disease caused by mutations in genes encoding desmosomal proteins and is characterised by fibrofatty replacement occurring predominantly in the right ventricle and can result in sudden cardiac death. Naxos and Carvajal syndrome, autosomal recessive forms of ARVC/D, are characterised by involvement of the right and/or left ventricle in association with palmoplantar keratoderma and woolly hair. The aim of the present study has been to screen for mutations in the desmosomal protein genes of two unrelated patients with Naxos-Carvajal syndrome. METHODS AND
RESULTS: Desmosomal protein genes were screened for mutations by polymerase chain reaction as well as direct sequencing approach. In each patient we identified a single heterozygous de novo mutation in the desmoplakin gene DSP, p.Leu583Pro and p.Thr564Ile, leading to severe combined cardiac/dermatological and cardiac/dermatological/dental phenotypes. The DSP missense mutations are localised in the N terminal domain of desmoplakin.
CONCLUSION: The identified variations in DSP involve highly conserved residues. Moreover, the variations are de novo mutations and they are localised in critical protein domains that appear to be mutation hot spots. We assume that these heterozygous variations are causal for the mixed Naxos-Carvajal syndrome phenotype in the screened patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949226     DOI: 10.4414/smw.2012.13670

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  11 in total

Review 1.  Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

Review 2.  Desmosome regulation and signaling in disease.

Authors:  Joshua A Broussard; Spiro Getsios; Kathleen J Green
Journal:  Cell Tissue Res       Date:  2015-02-19       Impact factor: 5.249

Review 3.  Intercalated discs: cellular adhesion and signaling in heart health and diseases.

Authors:  Guangze Zhao; Ye Qiu; Huifang M Zhang; Decheng Yang
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

Review 4.  [Palmoplantar dermatoses: when should genes be considered?].

Authors:  C Seebode; S Schiller; S Emmert; K Giehl
Journal:  Hautarzt       Date:  2014-06       Impact factor: 0.751

Review 5.  Science and practice of arrhythmogenic cardiomyopathy: A paradigm shift.

Authors:  Mohamed Elmaghawry; Federico Migliore; Nazar Mohammed; Despina Sanoudou; Mohammed Alhashemi
Journal:  Glob Cardiol Sci Pract       Date:  2013-11-01

6.  Autosomal dominant Carvajal plus syndrome due to the novel desmoplakin mutation c.1678A > T (p.Ile560Phe).

Authors:  Josef Finsterer; Claudia Stöllberger; Eva Wollmann; Susanne Dertinger; Franco Laccone
Journal:  Mol Genet Metab Rep       Date:  2016-06-02

7.  DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy.

Authors:  Krista Heliö; Tiia Kangas-Kontio; Sini Weckström; Sari U M Vanninen; Katriina Aalto-Setälä; Tero-Pekka Alastalo; Samuel Myllykangas; Tiina M Heliö; Juha W Koskenvuo
Journal:  BMC Med Genet       Date:  2020-01-31       Impact factor: 2.103

8.  Analysis of De Novo Mutations in Sporadic Cardiomyopathies Emphasizes Their Clinical Relevance and Points to Novel Candidate Genes.

Authors:  Maria Franaszczyk; Grazyna Truszkowska; Przemyslaw Chmielewski; Malgorzata Rydzanicz; Joanna Kosinska; Tomasz Rywik; Anna Biernacka; Mateusz Spiewak; Grazyna Kostrzewa; Malgorzata Stepien-Wojno; Piotr Stawinski; Maria Bilinska; Pawel Krajewski; Tomasz Zielinski; Anna Lutynska; Zofia T Bilinska; Rafal Ploski
Journal:  J Clin Med       Date:  2020-01-29       Impact factor: 4.241

9.  Dominant de novo DSP mutations cause erythrokeratodermia-cardiomyopathy syndrome.

Authors:  Lynn M Boyden; Chen Y Kam; Angela Hernández-Martín; Jing Zhou; Brittany G Craiglow; Robert Sidbury; Erin F Mathes; Sheilagh M Maguiness; Debra A Crumrine; Mary L Williams; Ronghua Hu; Richard P Lifton; Peter M Elias; Kathleen J Green; Keith A Choate
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

Review 10.  Naxos disease: from the origin to today.

Authors:  Guo-Liang Li; Ardan M Saguner; Guy H Fontaine
Journal:  Orphanet J Rare Dis       Date:  2018-05-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.